Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02159's PB Ratio is ranked worse than 67.87% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.035
vs HKSE:02159: 3.09
During the past 12 months, Mediwelcome Healthcare Management & Technology's average Book Value Per Share Growth Rate was 55.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -25.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -21.90% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Mediwelcome Healthcare Management & Technology was 36.90% per year. The lowest was -38.80% per year. And the median was 0.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Mediwelcome Healthcare Management & Technology PB Ratio Related Terms
Mediwelcome Healthcare Management & Technology PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology PB Ratio Chart
Mediwelcome Healthcare Management & Technology Annual Data
HKSE:02159 vs VEEV, BTSG, HQY: PB Ratio Comparison
For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediwelcome Healthcare Management & Technology PB Ratio vs Healthcare Providers & Services Industry
Mediwelcome Healthcare Management & Technology PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a PB Ratio of 3.08 as of Aug. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. This is 185% above median its historical median of 1.08. Over the past decade, Mediwelcome Healthcare Management & Technology's PB Ratio has ranged from 0.38 to 4.61. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #414 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 67.9%.
Is Mediwelcome Healthcare Management & Technology's PB Ratio too high?
Mediwelcome Healthcare Management & Technology's current PB Ratio of 3.08 is 185% above median its 10-year median of 1.08. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 4.61. The Healthcare Providers & Services industry median PB Ratio is 2.04. Mediwelcome Healthcare Management & Technology's value of 3.08 is 51.4% above this industry median. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #414 out of 610 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #414 out of 610 companies for PB Ratio. This places Mediwelcome Healthcare Management & Technology in the lower half of its industry. The industry median PB Ratio is 2.04. Mediwelcome Healthcare Management & Technology's value of 3.08 is 51.4% above this benchmark. Historically, Mediwelcome Healthcare Management & Technology's own PB Ratio has ranged from 0.38 to 4.61 over the past decade. While the company's 10-year median is 1.08 vs. the industry median of 2.04, Mediwelcome Healthcare Management & Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.04, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current PB Ratio of 3.08 is 51.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current PB Ratio is 3.08, which is 185% above median its own 10-year median of 1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.78, compared to a current price of HK$1.76 — trading 125.6% above its estimated fair value. The current PB Ratio is 3.08, which is 185% above median its 10-year median of 1.08 and 51.4% above the Healthcare Providers & Services industry median of 2.04. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current PB Ratio is 3.08 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued.
The current stock price of HK$1.76 is trading 125.6% above its estimated GF Value™ of HK$0.78.
GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02159:
PB Ratio: 3.08 (185% above median its 10-year median of 1.08)
GF Value™: HK$0.78 vs. price of HK$1.76 (125.6% above fair value)
Industry Position: 51.4% above the Healthcare Providers & Services median (#414 of 610)
No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
56GF Score
Get the complete analysis for HKSE:02159
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02159 has been successfully added to your 
